Suppr超能文献

Emerging new evidence for the treatment of pulmonary sarcomatoid carcinoma.

作者信息

Akaba Tomohiro, Arimura Ken, Tagaya Etsuko

机构信息

Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

J Thorac Dis. 2023 Mar 31;15(3):953-955. doi: 10.21037/jtd-22-1775. Epub 2023 Feb 23.

Abstract
摘要

相似文献

1
Emerging new evidence for the treatment of pulmonary sarcomatoid carcinoma.
J Thorac Dis. 2023 Mar 31;15(3):953-955. doi: 10.21037/jtd-22-1775. Epub 2023 Feb 23.
3
Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinoma.
J Thorac Dis. 2022 Oct;14(10):3773-3781. doi: 10.21037/jtd-22-393.
4
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.
Urol Oncol. 2015 Oct;33(10):427.e17-23. doi: 10.1016/j.urolonc.2015.04.011. Epub 2015 May 23.
6
The treatment of advanced pulmonary sarcomatoid carcinoma.
Future Oncol. 2022 Feb;18(6):727-738. doi: 10.2217/fon-2021-1071. Epub 2021 Dec 9.
7
Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.
World J Surg Oncol. 2013 Oct 2;11:252. doi: 10.1186/1477-7819-11-252.
8
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor.
Transl Oncol. 2017 Apr;10(2):115-120. doi: 10.1016/j.tranon.2016.11.009. Epub 2017 Jan 10.
9
The Prognostic Significance Of JMJD3 In Primary Sarcomatoid Carcinoma Of The Lung, A Rare Subtype Of Lung Cancer.
Onco Targets Ther. 2019 Nov 7;12:9385-9393. doi: 10.2147/OTT.S225596. eCollection 2019.
10
[Current Status of Diagnosis and Treatment of Pulmonary Sarcomatoid Carcinoma].
Zhongguo Fei Ai Za Zhi. 2018 Dec 20;21(12):902-906. doi: 10.3779/j.issn.1009-3419.2018.12.07.

本文引用的文献

1
Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinoma.
J Thorac Dis. 2022 Oct;14(10):3773-3781. doi: 10.21037/jtd-22-393.
2
Immunophenotyping of pulmonary sarcomatoid carcinoma.
Front Immunol. 2022 Oct 20;13:976739. doi: 10.3389/fimmu.2022.976739. eCollection 2022.
3
MET alterations in advanced pulmonary sarcomatoid carcinoma.
Front Oncol. 2022 Sep 23;12:1017026. doi: 10.3389/fonc.2022.1017026. eCollection 2022.
4
Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma.
Front Oncol. 2022 May 3;12:833486. doi: 10.3389/fonc.2022.833486. eCollection 2022.
5
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.
Immunotherapy. 2021 Jul;13(10):799-806. doi: 10.2217/imt-2020-0311. Epub 2021 May 25.
6
Recurrent spindle cell carcinoma of the lung successfully treated by chemoimmunotherapy.
Respirol Case Rep. 2021 May 7;9(6):e00757. doi: 10.1002/rcr2.757. eCollection 2021 Jun.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma.
J Thorac Oncol. 2020 May;15(5):860-866. doi: 10.1016/j.jtho.2020.01.014. Epub 2020 Jan 25.
10
c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas.
J Thorac Oncol. 2018 Dec;13(12):1962-1967. doi: 10.1016/j.jtho.2018.08.008. Epub 2018 Aug 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验